Updates on Osteoporosis in Men.
| Autor: | Diab DL; Division of Endocrinology/Metabolism, Department of Internal Medicine, Cincinnati VA Medical Center, University of Cincinnati Bone Health and Osteoporosis, 231 Albert Sabin Way, MSB 7th Floor, Cincinnati, OH 45267, USA. Electronic address: diabd@ucmail.uc.edu., Watts NB; Mercy Health Osteoporosis and Bone Health Services, 4760 E. Galbraith Road, Suite 212, Cincinnati, OH 45236, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Endocrinology and metabolism clinics of North America [Endocrinol Metab Clin North Am] 2021 Jun; Vol. 50 (2), pp. 239-249. |
| DOI: | 10.1016/j.ecl.2021.03.001 |
| Abstrakt: | Osteoporosis is less common in men than women; however, the mortality rate associated with major fragility fractures is higher in men. The diagnosis of osteoporosis is established by measurement of bone mineral density or by the presence of a fragility fracture, especially spine or hip fracture. However, many men at high risk of fracture will not meet the T-score criteria for osteoporosis, so fracture risk calculation, with a tool such as FRAX, should be performed. Bone-active agents should be prescribed for men at high risk of fracture to decrease fracture risk, and therapy must be individualized. Competing Interests: Disclosure Dr D.L. Diab has nothing to disclose. Dr N.B. Watts is a speaker for Amgen and Radius. (Copyright © 2021 Elsevier Inc. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|